Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX). And retail traders should know. We noticed this today when the positions showed up on publicly ...
Viking aims to enter the billion-dollar weight loss drug market. Early last year, Viking announced results from a phase 2 trial of its injectable weight loss drug candidate and saw its stock surge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback